Flagship explainer
What drives INTEGRATED BIOPHARMA INC’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| $808000 | FY2025 |
| |
| Income before tax | $2.1M | FY2025 |
|
| Operating income | $2M | FY2025 |
|
| $54.4M | FY2025 |
| |
| Ending assets | $24.9M | FY2025 |
|
| Beginning assets | $26.2M | FY2024 |
|
| $20.3M | FY2025 |
| |
| $19.2M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001437749-25-029711